40 results on '"Adolfsson, Jan"'
Search Results
2. Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data
3. The STHLM3-model, Risk-based Prostate Cancer Testing Identifies Men at High Risk Without Inducing Negative Psychosocial Effects
4. Poor Follow-up After Elevated Prostate-specific Antigen Tests: A Population-based Cohort Study
5. The use of palliative medications before death from prostate cancer: Swedish population-based study with a comparative overview of European data
6. Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events
7. Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study
8. Rehospitalization after Radical Prostatectomy in a Nationwide, Population Based Study
9. Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe Sweden
10. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer
11. Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
12. The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic Value of Tumour Ploidy and Comorbidity
13. The Choice Between a Therapy-Induced Long-Term Symptom and Shortened Survival Due to Prostate Cancer
14. HIP FRACTURES IN MEN WITH PROSTATE CANCER TREATED WITH ORCHIECTOMY
15. The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50–69 yr Compared with Current Prostate Cancer Testing
16. Balancing Overdiagnosis and Early Detection of Prostate Cancer using the Stockholm-3 Model
17. Detection of Prostate Cancer Using a Multistep Approach with Prostate-specific Antigen, the Stockholm 3 Test, and Targeted Biopsies: The STHLM3 MRI Project
18. BACILLUS CALMETTE-GUERIN INDUCES LONG-TERM LOCAL FORMATION OF NITRIC OXIDE IN THE BLADDER VIA THE INDUCTION OF NITRIC OXIDE SYNTHASE ACTIVITY IN UROTHELIAL CELLS
19. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL
20. Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines
21. DEFERRED TREATMENT OF LOCALLY ADVANCED NONMETASTATIC PROSTATE CANCER: A LONG-TERM FOLLOWUP
22. Editorial Comment on: Predicting the Probability of Deferred Radical Treatment for Localised Prostate Cancer Managed by Active Surveillance
23. The Management of Category T1a–T1b (Incidental) Prostate Cancer: Can We Predict Who Needs Treatment?
24. Castration and osteoporisrelated fractures in a 30-year follow-up
25. Predisone has quality-of-life benefits over flutamide in the treatment of hormone-resistant prostate cancer
26. EDITORIAL: QUALITY OF LIFE
27. Effects of l-arginine treatment on symptoms and bladder nitric oxide levels in patients with interstitial cystitis
28. Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system
29. Deferred treatment of clinically localized low-grade prostate cancer: Actual 10-year and projected 15-year follow-up of the karolinska series
30. Assessment of endpoints for clinical trials for localized prostate cancer
31. Distinguishing prognostic and treatment-predictive information for localized prostate cancer
32. Bias due to observation of different parts of a nonconstant hazard curve over time
33. Comparison of transrectal prostate digital aspiration and ultrasound-guided core biopsies in 99 men
34. Deferred Treatment of Clinically Localized Low Grade Prostate Cancer: The Experience From A Prospective Series at The Karolinska Hospital
35. Natural Course of Clinically Localized Prostate Adenocarcinoma in Men Less Than 70 Years Old
36. Deferred Treatment of Low Grade Stage T3 Prostate Cancer without Distant Metastases
37. The Prognostic Value of Modal Deoxyribonucleic Acid in Low Grade, Low Stage Untreated Prostate Cancer
38. Evaluation of Tumor Progression by Repeated Fine Needle Biopsies in Prostate Adenocarcinoma: Modal Deoxyribonucleic Acid Value and Cytological Differentiation
39. The Natural Course of Prostatic Carcinoma in Relation to Initial Cytological Grade
40. Introduction: Localized prostate cancer—to defer treatment or to excise radically?: Deferred treatment for clinically localized prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.